Kawasuji Takashi, Fuji Masahiro, Yoshinaga Tomokazu, Sato Akihiko, Fujiwara Tamio, Kiyama Ryuichi
Shionogi Research Laboratories, Shionogi & Company, Ltd, Sagisu, Fukushima-ku, Osaka 553-0002, Japan.
Bioorg Med Chem. 2006 Dec 15;14(24):8420-9. doi: 10.1016/j.bmc.2006.08.043. Epub 2006 Sep 26.
We propose a two-metal binding model as a potential mechanism of chelating inhibitors against HIV integrase (HIV IN) represented by 2-hydroxy-3-heteroaryl acrylic acids (HHAAs). Potential inhibitors would bind to two metal ions in the active site of HIV IN to prevent human DNA from undergoing the integration reaction. Correlation of the results of metal (Mg(2+) and Mn(2+)) titration studies with HIV IN inhibition for a series of active and inactive compounds provides support for the model. Results suggest Mg(2+) is an essential cofactor for chelating inhibitors.
我们提出一种双金属结合模型,作为以2-羟基-3-杂芳基丙烯酸(HHAA)为代表的螯合抑制剂抗HIV整合酶(HIV IN)的潜在机制。潜在抑制剂会与HIV IN活性位点中的两个金属离子结合,以阻止人类DNA进行整合反应。一系列活性和非活性化合物的金属(Mg(2+)和Mn(2+))滴定研究结果与HIV IN抑制作用之间的相关性为该模型提供了支持。结果表明Mg(2+)是螯合抑制剂的必需辅因子。